| Actemra SC (tocilizumab SC) / Roche, Halozyme |
ACTRN12621001695897: A randomised controlled trial to compare drug dose reduction strategies in adults with rheumatoid arthritis and psoriatic arthritis for safer and more efficient drug use |
|
|
| Recruiting | 4 | 324 | | | University of Sydney, Australian Government, Department of Health, National Health and Medical Research Council, Medical Research Future Fund (MRFF) | Rheumatoid arthritis, Psoriatic arthritis | | | | |
| Recruiting | 4 | 98 | Europe | Tocilizumab | Reade Rheumatology Research Institute, ZonMw: The Netherlands Organisation for Health Research and Development | Rheumatoid Arthritis | 12/24 | 12/24 | | |
| Recruiting | 4 | 224 | Europe | Tocilizumab Prefilled Syringe, RoActemra, Abatacept Prefilled Syringe, Orencia | Lille Catholic University | Arthritis, Rheumatoid | 09/24 | 11/24 | | |
REPAIR, NCT02765074: Filling Bone Erosions: a Longitudinal Multicentric HR-pQCT Study of Subcutaneous Tocilizumab in Rheumatoid Arthritis |
|
|
| Recruiting | 4 | 60 | Europe | subcutaneous tocilizumab, Roactemra | Centre Hospitalier Régional d'Orléans, Rennes University Hospital | Rheumatoid Arthritis | 06/25 | 06/25 | | |
